Aug 28 (Reuters) - Critical Outcome Technologies Inc COT.V
* Critical Outcome Technologies announces fourth quarter and full year 2017 financial results
* Q4 loss per share C$0.13
* Critical Outcome Technologies - Following completion of preclinical studies co expects to file an IND application for COTI-219 with the FDA
* IND filing for COTI-2 with FDA expected in early 2018